| Dr Saumya Goel Aujla, MD | |
|
3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 | |
| (615) 322-5000 | |
| Not Available |
| Full Name | Dr Saumya Goel Aujla |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326539909 | NPI | - | NPPES |
| Entity Name | Vanderbilt University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
The team of Eva González-Suarez, from the CNIO and IDIBELL, and the team of Christos Sotiriou, from the Jules Bordet Institute, demonstrate that a drug already used to treat osteoporosis promotes the infiltration of immune cells in breast tumors.
PET/CT imaging exhibits significantly higher sensitivity, specificity and accuracy than conventional imaging when it comes to detecting malignant tumors in children, according to research published in the December issue of the Journal of Nuclear Medicine.
For medicinal chemists, making tweaks to peptide structures is key to developing new drug candidates. Now, researchers have demonstrated that two iron-containing small-molecule catalysts can help turn certain types of amino acids - the building blocks of peptides and proteins - into an array of potential new forms, even when part of a larger peptide, while preserving a crucial aspect of their chemistry: chirality, or "handedness."
Independent group leaders Eleanor Scerri and Denise Kuehnert of the Max Planck Institute for the Science of Human History (MPI-SHH) have teamed up with other colleagues from the institute and beyond to comment in Nature Ecology & Evolution on the future of field-based sciences in a COVID-19 world.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that its president and CEO, Manish Singh Ph.D., will be presenting at the Immunotherapeutics Partnering and Deal Making Conference, which will take place in San Diego, California on January 30-31, 2012.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Saumya Goel Aujla, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: () - | Dr Saumya Goel Aujla, MD 3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 Ph: (615) 322-5000 |
News Archive
The team of Eva González-Suarez, from the CNIO and IDIBELL, and the team of Christos Sotiriou, from the Jules Bordet Institute, demonstrate that a drug already used to treat osteoporosis promotes the infiltration of immune cells in breast tumors.
PET/CT imaging exhibits significantly higher sensitivity, specificity and accuracy than conventional imaging when it comes to detecting malignant tumors in children, according to research published in the December issue of the Journal of Nuclear Medicine.
For medicinal chemists, making tweaks to peptide structures is key to developing new drug candidates. Now, researchers have demonstrated that two iron-containing small-molecule catalysts can help turn certain types of amino acids - the building blocks of peptides and proteins - into an array of potential new forms, even when part of a larger peptide, while preserving a crucial aspect of their chemistry: chirality, or "handedness."
Independent group leaders Eleanor Scerri and Denise Kuehnert of the Max Planck Institute for the Science of Human History (MPI-SHH) have teamed up with other colleagues from the institute and beyond to comment in Nature Ecology & Evolution on the future of field-based sciences in a COVID-19 world.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that its president and CEO, Manish Singh Ph.D., will be presenting at the Immunotherapeutics Partnering and Deal Making Conference, which will take place in San Diego, California on January 30-31, 2012.
› Verified 8 days ago
Robert Baum, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Bhaskar Mukherji, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Robert J Serro, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3443 Dickerson Pike, Suite G-30, Nashville, TN 37207 Phone: 615-868-4600 Fax: 615-868-4001 | |
Heidi Chen, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Carolyn Thompson Chudy, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2908 Poston Ave Ste 2002, Nashville, TN 37203 Phone: 866-719-9611 | |
Leslie Vicky Mullins, PAC Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Gina M Walton, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 |